Abiopharma

Schleimer Andrew M 🟡 adjusted position in 9.9K shares (1 derivative) of TKO Group Holdings, Inc. (TKO) at $194.39 ($1.9M) Transaction Date: Aug 17, 2026 | Filing ID: 357351

Emanuel Ariel 🟡 adjusted position in 24.7K shares (1 derivative) of TKO Group Holdings, Inc. (TKO) at $194.39 ($4.8M) Transaction Date: Aug 17, 2026 | Filing ID: 357350

SHAPIRO MARK S 🟡 adjusted position in 19.1K shares (1 derivative) of TKO Group Holdings, Inc. (TKO) at $194.39 ($3.7M) Transaction Date: Aug 17, 2026 | Filing ID: 357349

Khan Nick 🟡 adjusted position in 14.8K shares (1 derivative) of TKO Group Holdings, Inc. (TKO) at $201.91 ($2.9M) Transaction Date: Aug 17, 2026 | Filing ID: 357348

Director Rajaram Gokul 🔴 sold 1.1K shares of PINTEREST, INC. (PINS) at $23.03 Transaction Date: Aug 19, 2026 | Filing ID: 000013

Dines Daniel 🔴 sold 1.4M shares of UiPath, Inc. (PATH) at $16.07 ($22.5M) Transaction Date: Aug 19, 2026 | Filing ID: 000017

Park Ha Biological Technology Co, Ltd. Stockholders Have an Opportunity to Lead the Class Action Against BYAH- Contact Robbins LLP for Information About Recovering Your Losses

Lin Xichen 🟡 adjusted position in 11.8K shares (5 derivative) of Structure Therapeutics Inc. (GPCR) at $0.34 Transaction Date: Aug 18, 2026 | Filing ID: 000008

Knechtel Fred S. 🟡 adjusted position in 0 shares (1 derivative) of Profusa, Inc. (PFSA) at $4.28 ($2.6M) Transaction Date: Aug 12, 2026 | Filing ID: 091841

STOVER JACK E 🟡 adjusted position in 0 shares (1 derivative) of Profusa, Inc. (PFSA) at $4.28 ($2.6M) Transaction Date: Aug 12, 2026 | Filing ID: 091839

PAGE STEPHEN F 🔴 sold 250 shares of AeroVironment Inc (AVAV) at $191.98 Transaction Date: Aug 17, 2026 | Filing ID: 000022

Director NEUPERT PETER M 🟡 adjusted position in 124.7K shares (1 derivative) of Adaptive Biotechnologies Corp (ADPT) at $25.23 ($3.3M) Transaction Date: Aug 17, 2026 | Filing ID: 000003

General Announcement: OCBC priced GBP 1 billion floating rate covered bonds due 2029

Director Moore Alexander D. 🔴 sold 16.0K shares of Palantir Technologies Inc. (PLTR) at $175.84 ($2.8M) Transaction Date: Aug 17, 2026 | Filing ID: 000020

Director Torley Helen 🟡 adjusted position in 60.0K shares (3 derivative) of HALOZYME THERAPEUTICS, INC. (HALO) at $107.77 ($8.5M) Transaction Date: Aug 17, 2026 | Filing ID: 000108